|
Sign In to gain access to subscriptions and/or personal tools.
|
Acute Changes in Lung Histopathology and Bronchoalveolar Lavage Parameters in Mice Exposed to the Choking Agent Gas Phosgene
Steven M. Duniho
Comparative Pathology US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland 21010-5400
Jamie Martin
Comparative Pathology US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland 21010-5400
Jeffry S. Forster
Pharmacology Divisions, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland 21010-5400
Matthew B. Cascio
Pharmacology Divisions, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland 21010-5400
Ted S. Moran
Pharmacology Divisions, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland 21010-5400
Laura B. Carpin
Pharmacology Divisions, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland 21010-5400
Alfred M. Sciuto
Pharmacology Divisions, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland 21010-5400
Phosgene (CG) is a highly irritant gas widely used industrially as a chemical intermediate for the production of dyes, pesticides, and plastics, and can cause life-threatening pulmonary edema within 24 hours of exposure. This study was designed to investigate acute changes in lung tissue histopathology and selected bronchoalveolar lavage fl uid (BALF) factors over time to determine early diagnostic indicators of exposure. Three groups of 40 male mice each were exposed to 32 mg/m 3 (8 ppm) CG for 20 minutes, and 3 groups of 40 control male mice were exposed to fi ltered room air for 20 minutes, both exposures were followed by room air washout for 5 minutes. At 1, 4, 8, 12, 24, 48, and 72 hours after exposure each group of mice was euthanized and processed for histopathology, bronchoalveolar lavage or gravimetric measurements, respectively. Over time, the histopathological lesions were characterized by acute changes consisting of alveolar and interstitial edema, fi brin and hemorrhage, followed by signifi cant alveolar and interstitial fl ooding with infl ammatory cell infi ltrates and scattered bronchiolar and terminal airway epithelial degeneration and necrosis. From 48 to 72 hours, there was partial resolution of the edema and degenerative changes, followed by epithelial and fi broblastic regeneration centered on the terminal bronchiolar areas. Bronchoalveolar lavage was processed for cell differential counts, LDH, and protein determination. Comparative analysis revealed signifi cant increases in both postexposure lung wet/dry weight ratios, and early elevations of BALF LDH and protein, and later elevations in leukocytes. This article describes the use of histopathology to chronicle the temporal pulmonary changes subsequent to whole body exposure to phosgene, and correlate these changes with BALF ingredients and postexposure lung wet weights in an effort to characterize toxic gas-induced acute lung injury and identify early markers of phosgene exposure.
Key Words: Edema • lung • toxicity • wet/dry weight ratio • LDH • protein.
References
- Brown JE, Birky MM (1980). Phosgene in the thermal decomposition products of poly(vinylchloride): Generation, detection, and measurement. J Anal Toxicol 4: 166—174.[Web of Science][Medline]
[Order article via Infotrieve]
- Cucinell SA (1974). Review of the toxicity of long-term phosgene exposure. Arch Environ Hlth 28: 272—275.[Web of Science][Medline]
[Order article via Infotrieve]
- Currie WD, Hatch GE, Frosolono M. (1987). Changes in ATP concentration in the rat lung after low-level phosgene exposure. J Biochem Toxicol 2: 105—114.[CrossRef][Medline]
[Order article via Infotrieve]
- Currie WD, Hatch GE, Frosolono MF (1987). Pulmonary alterations in rats due to acute phosgene inhalation. Fund Appl Tox 8: 107—114.[CrossRef]
- Diller WF (1978). Medical phosgene problems and their possible solution. J Occup Med 20: 189—193.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Diller WF, Bruch J., Dehnen W. (1985). Pulmonary changes in the rat following low phosgene exposure. Arch Toxicol 57(3): 184—190.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Gerritsen WB, Buschman CH (1960). Phosgenepoisoning caused by the use of chemical paint removers containing methylene chloride in ill-ventilated rooms heated by kerosene stoves. Br J Ind Med 17: 187—189.[Medline]
[Order article via Infotrieve]
- Ghio AJ, Kennedy TP, Hatch GE, Tepper JS (1991). Reduction of neutrophi l infl ux diminishes lung injury and mortality following phosgene inhalation. J Appl Physiol 71(2): 657—665.[Abstract/Free Full Text]
- Guo Y-L., Kennedy TP, Michael JR, Sciuto AM, Ghio AJ, Adkinson NF, Gurtner GH (1990). Mechanisms of phosgene-induced lung injury: Role of arachidonate mediators. J Appl Physiol 69(5): 1615—1622.[Abstract/Free Full Text]
- Guth DJ, Warren DL, Last JA ( 1986). Comparative sensitivity of measurements of lung damage made by bronchoalveolar lavage after short-term exposure of rats to ozone. Toxicology 40: 131—143.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Henderson RF, Mauderly JL, Pickrell JA, Hahn FF, Muhle H., Rebar AH (1987). Comparative study of bronchoalveolar lavage fl uid: Effects of species, age, and method of lavage. Exp Lung Res 13: 329— 342.
- Kennedy TP, Michael JR, Hoidal J., Hasty D., Sciuto AM, Hopkins C., Lazar R., Bysani GG, Gurtner GH (1989). Dibutyryl cAMP, aminophylline and adrenergic agonists protect against pulmonary edema caused by phosgene. J Appl Physiol 67(6): 2542—2552.[Abstract/Free Full Text]
- Khan MF, Gutpa GSD (1991). Cellular and biochemical indices of bronchoalveolar lavage for detection of lung injury following insult by airborne toxicants. Toxicol Lett 58: 239—255.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Kodavanti UP, Costa DL, Giri SN, Starcher B., Hatch GE (1997). Pulmonary structural and extracellular matrix alterations in Fisher 344 rats following subchronic phosgene exposure. Fund Appl Toxicol 37: 54— 63.
- Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951). Protein measurement with Folin phenol reagent. J Biol Chem 193: 265—275.[Free Full Text]
- Mauderly JL (1977). Bronchopulmonary lavage of small laboratory animals. Lab Anim Sci 27(2): 255—261.[Web of Science][Medline]
[Order article via Infotrieve]
- Mobay Chemical Company, Phosgene—An important chemical, 9 pp, (1988).
- Niosh (1993). Criteria for a recommended standard: Occupational exposure to phosgene. USDEW, PHS, CDC publication #76—137, Washington, DC.
- Pawlowski R., Frosolono MF (1977). Effect of phosgene on rat lung after a single high-level exposure II. Ultrastructural alterations. Arch Environ Hlth 32:278—283.[Web of Science][Medline]
[Order article via Infotrieve]
- Pino MV, Levin JR, Stovall MY, Hyde DM ( 1992). Pulmonary infl ammation and epithelial injury in response to acute ozone exposure in rats. Toxicol Appl Pharmacol112: 64—72.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sciuto AM, Strickland PT, Kennedy TP, Guo Y-L., Gurtner GH (1996). Intratracheal administration of dibutyryl cAMP attenuates edema formation in phosgene-induce dacute lung injury. J Appl Physiol 80(1): 149— 157.
- Sciuto AM, Strickland PT, Kennedy TP, Gurtner GH (1995). Protective effects of N-acetylcysteine treatment after phosgene exposure in rabbits. Am J Resp Crit Care Med 151: 768—772.[Abstract]
- Sebring RJ, Archuletta DC, Deshpande A., Lehnert BE (1994). Light and electron microscopic changes during the course of development of phosgene-induce dlung injury. Toxicologist (Abs.) 14: 309.
- Urbanetti JS (1989). Phosgene: Clinical importance and management. In: Proceedings of Workshop on Acute Lung Injury and Pulmonar y Edema (AD A216293), United States Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland, pp 105—119.
Toxicologic Pathology, Vol. 30, No. 3,
339-349 (2002)
DOI: 10.1080/01926230252929918
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
A. Khanolkar, S. M. Hartwig, B. A. Haag, D. K. Meyerholz, J. T. Harty, and S. M. Varga
Toll-Like Receptor 4 Deficiency Increases Disease and Mortality after Mouse Hepatitis Virus Type 1 Infection of Susceptible C3H Mice
J. Virol.,
September 1, 2009;
83(17):
8946 - 8956.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
